Clinical Trial Update: A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury [Phase 2]

View source ↗

Summary

Phase 2 trial assessing OCE-205 in participants with cirrhosis and ascites who developed hepatorenal syndrome-acute kidney injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Hepatorenal Syndrome
• Kidney Injury

Drugs mentioned

• OCE-205

Snippet

Sponsor: Ocelot Bio, Inc | Conditions: Cirrhosis, Ascites | Phase 2 | Status: COMPLETED